Northern Trust’s Adaptive Biotechnologies ADPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$14.4M Buy
1,233,944
+180,354
+17% +$2.1M ﹤0.01% 1854
2025
Q1
$7.83M Sell
1,053,590
-40,391
-4% -$300K ﹤0.01% 2183
2024
Q4
$6.56M Buy
1,093,981
+130,449
+14% +$782K ﹤0.01% 2356
2024
Q3
$4.93M Buy
963,532
+35,651
+4% +$183K ﹤0.01% 2484
2024
Q2
$3.36M Sell
927,881
-96,250
-9% -$348K ﹤0.01% 2618
2024
Q1
$3.29M Sell
1,024,131
-18,854
-2% -$60.5K ﹤0.01% 2721
2023
Q4
$5.11M Buy
1,042,985
+8,163
+0.8% +$40K ﹤0.01% 2495
2023
Q3
$5.64M Sell
1,034,822
-14,235
-1% -$77.6K ﹤0.01% 2372
2023
Q2
$7.04M Buy
1,049,057
+16,351
+2% +$110K ﹤0.01% 2297
2023
Q1
$9.12M Buy
1,032,706
+37,297
+4% +$329K ﹤0.01% 2079
2022
Q4
$7.6M Sell
995,409
-170,425
-15% -$1.3M ﹤0.01% 2196
2022
Q3
$8.3M Buy
1,165,834
+154,272
+15% +$1.1M ﹤0.01% 2119
2022
Q2
$8.18M Buy
1,011,562
+547,304
+118% +$4.43M ﹤0.01% 2181
2022
Q1
$6.44M Sell
464,258
-2,149
-0.5% -$29.8K ﹤0.01% 2427
2021
Q4
$13.1M Sell
466,407
-11,813
-2% -$331K ﹤0.01% 2058
2021
Q3
$16.3M Buy
478,220
+15,154
+3% +$515K ﹤0.01% 1939
2021
Q2
$18.9M Buy
463,066
+43,596
+10% +$1.78M ﹤0.01% 1922
2021
Q1
$16.9M Buy
419,470
+9,534
+2% +$384K ﹤0.01% 1953
2020
Q4
$24.2M Buy
409,936
+707
+0.2% +$41.8K ﹤0.01% 1658
2020
Q3
$19.9M Buy
409,229
+49,463
+14% +$2.41M ﹤0.01% 1634
2020
Q2
$17.4M Sell
359,766
-14,785
-4% -$715K ﹤0.01% 1739
2020
Q1
$10.4M Buy
374,551
+261,558
+231% +$7.27M ﹤0.01% 1852
2019
Q4
$3.38M Sell
112,993
-701
-0.6% -$21K ﹤0.01% 2815
2019
Q3
$3.51M Buy
+113,694
New +$3.51M ﹤0.01% 2758
2019
Q2
Hold
0
4269